Eugenia Cella

Savona, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Prognostic impact of phosphatase and tensin homolog status in recurrent IDH-wildtype glioblastoma receiving second-line therapy.

Prognostic impact of phosphatase and tensin homolog status in recurrent IDH-wildtype glioblastoma receiving second-line therapy.

Journal: Neuro-oncology advances

Published: April 17, 2026

Diagnostic and predictive molecular biomarkers in brain tumors across the lifespan: an age-stratified consensus statement.

Diagnostic and predictive molecular biomarkers in brain tumors across the lifespan: an age-stratified consensus statement.

Journal: Journal of neuro-oncology

Published: September 15, 2025

Corrigendum to "PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives" [Cancer Treat. Rev. 131 (2024) 102850].

Corrigendum to "PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives" [Cancer Treat. Rev. 131 (2024) 102850].

Journal: Cancer treatment reviews

Published: December 21, 2024

PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives.

PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives.

Journal: Cancer treatment reviews

Published: September 23, 2024

Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors.

Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors.

Journal: Cell reports

Published: July 25, 2024

Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates.

Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 24, 2024

Prolonged response to entrectinib in an adult patient with recurrent glioblastoma harboring a GOPC::ROS1 fusion.

Prolonged response to entrectinib in an adult patient with recurrent glioblastoma harboring a GOPC::ROS1 fusion.

Journal: Neuro-oncology advances

Published: June 07, 2024

Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer.

Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer.

Journal: Cancer treatment reviews

Published: April 23, 2024

New Insights into Glioblastoma.

New Insights into Glioblastoma.

Journal: International journal of molecular sciences

Published: March 30, 2024

Systemic inflammatory markers and volume of enhancing tissue on post-contrast T1w MRI images in differentiating true tumor progression from pseudoprogression in high-grade glioma.

Systemic inflammatory markers and volume of enhancing tissue on post-contrast T1w MRI images in differentiating true tumor progression from pseudoprogression in high-grade glioma.

Journal: Clinical and translational radiation oncology

Published: March 10, 2024

Local therapy in glioma: An evolving paradigm from history to horizons (Review).

Local therapy in glioma: An evolving paradigm from history to horizons (Review).

Journal: Oncology letters

Published: February 13, 2024

Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.

Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.

Journal: Cells

Published: January 27, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026